Michael Kohrman

Michael Kohrman

Akron Children's Hospital - Akron / United States
Medical and Health Sciences / Pediatrics and Child Health
AD Scientific Index ID: 4978923
person_outline Michael Kohrman's MOST POPULAR ARTICLES
1-) Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled … DN Franz, E Belousova, S Sparagana, EM Bebin, M Frost, R Kuperman, ... The Lancet 381 (9861), 125-132, 2013 7912013
2-) ECoG gamma activity during a language task: differentiating expressive and receptive speech areas VL Towle, HA Yoon, M Castelle, JC Edgar, NM Biassou, DM Frim, ... Brain 131 (8), 2013-2027, 2008 2732008
3-) Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence AL Meoli, C Rosen, D Kristo, M Kohrman, N Gooneratne, RN Aguillard, ... Journal of clinical sleep medicine 1 (02), 173-187, 2005 1792005
4-) Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 studyDN Franz, E Belousova, S Sparagana, EM Bebin, MD Frost, R Kuperman, ...PloS one 11 (6), e0158476, 20162062016
5-) Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 studyDN Franz, E Belousova, S Sparagana, EM Bebin, M Frost, R Kuperman, ...The Lancet Oncology 15 (13), 1513-1520, 20141982014